Estimated delivery in United States, on Tuesday 18 Feb 2025
Product Information
Name:
BGT 226
Controlled Product
Synonyms:
- NVP BGT226
- NYP-BGT 226
- 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1H-imidazo[4,5-c]quinolin-2(3H)-one Maleate
Description:
Applications BGT 226 is a novel phosphatidyl inositol-3 kinase/mammalian target of rapamycin (PI3K/mTOR ) dual inhibitor which has shown to be effective with gefitinib in epidermal growth factor receptor (EGFR) inhibitor-sensitive non-small cell lung cancer (NSCLC) therapy.
References Katanasaka, Y., et. al.: Cancer Lett., 347, 196 (2014)
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:
Chemical properties
Molecular weight:
650.6
Formula:
C32H29F3N6O6
Color/Form:
Neat
InChI:
InChI=1S/C8H13NO2.ClH/c1-9(2)5-7-3-4-8(6-10)11-7;/h3-4,10H,5-6H2,1-2H3;1H
InChI key:
InChIKey=UDLQUVLALYCAMJ-UHFFFAOYSA-N
SMILES:
CN(C)Cc1ccc(CO)o1.Cl
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TR-B367500 BGT 226
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
